Breast Milk vs Sucrose in Relieving Procedural Pain in Preterm Neonates During Blood Draw by Automated Heel Lance
Primary Purpose
Pain
Status
Completed
Phase
Phase 4
Locations
United States
Study Type
Interventional
Intervention
Breast Human Milk
24 % Sucrose
Sponsored by
About this trial
This is an interventional treatment trial for Pain focused on measuring Pain management in preterm neonates
Eligibility Criteria
Inclusion Criteria:
- All Infants with gestational age between 30 1/7 and 36 6/7 weeks
- Within 30 days of post-natal life
- Breast milk is available for the neonate
- Scheduled for a blood draw
Exclusion Criteria:
- Neonates on intravenous or peroral medications for sedation/analgesia or anti-epileptics
- Infants diagnosed with neonatal abstinence syndrome and neonatal encephalopathy
- Infants who are critically ill, on assisted ventilation > 2L HFNC and on ionotropic support
- Infants with major congenital abnormalities/dysmorphism
Sites / Locations
- Detroit Medical center
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Other
Arm Label
Breast Milk
24 %Sucrose
Arm Description
2 ml of Breast milk given one time, two minutes prior to the heel lance
0.5 ml sucrose to be given once, two minutes prior to the heel lance
Outcomes
Primary Outcome Measures
Pain Profile
Premature Infant Pain Profile- Revised pain profile is used to give pain scores to the participants. Minimum score and maximum scores on the scale are zero and twenty one. The pain scores increases with increasing severity of pain.
Secondary Outcome Measures
Pain Profile
Premature Infant Pain Profile- Revised pain profile is used to give pain scores to the participants.
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT04898881
Brief Title
Breast Milk vs Sucrose in Relieving Procedural Pain in Preterm Neonates During Blood Draw by Automated Heel Lance
Official Title
Breast Milk vs 24 % Sucrose in Procedural Pain Relief in Preterm Infants: Randomized Controlled Trial
Study Type
Interventional
2. Study Status
Record Verification Date
May 2021
Overall Recruitment Status
Completed
Study Start Date
January 1, 2020 (Actual)
Primary Completion Date
May 7, 2021 (Actual)
Study Completion Date
May 7, 2021 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Wayne State University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Skin breaking procedure through an automated heel lancet for blood draws is a common painful procedure in the Neonatal Intensive care unit (NICU). Recurrent pain in preterm neonates is associated with long-term complications. The primary objective of the study is to compare pain scores between two groups (24% sucrose and breast milk) during blood draw using an automated heel lancet in preterm neonates. The investigator conducted a prospective randomized controlled trial in preterm neonates, to compare the pain scores in infants receiving either breast milk or sucrose. Premature Infant pain profile- Revised pain profile is used to assign pain scores. The primary outcome measure is the comparison of pain scores between the two groups.
Detailed Description
Blood draw by automated heel lancet is a common painful procedure in the Neonatal Intensive care units (NICU). The cutaneous sensory receptors on all mucosal and cutaneous surfaces are developed by 20 weeks gestational age (GA) and the neuronal circuits that carry pain stimuli from skin to cerebral cortex are developed by around 26 weeks of GA. Recurrent pain in preterm neonates impacts their postnatal growth, development, is associated with altered pain perception, and increased behavioral responses for future painful procedures.
Oral sucrose is a commonly administered and effective non-pharmacologic intervention used in the NICU for pain relief. There is insufficient evidence on its mechanism of action, minimum effective dose, the effect of repeated doses on long-term neurodevelopmental outcomes, and the consistency in providing pain relief with repeated doses over time. Moreover, the analgesic effect of sucrose is a developmentally transient phenomenon. Another non-pharmacologic intervention studied for pain relief in neonates is breast milk. The analgesic property of breast milk is presumed to be from its sweet taste from lactose, flavor, and odor. Breast milk has high levels of tryptophan, a melatonin precursor which may increase secretion of beta-endorphin, an endogenous opioid.
There is a paucity of data comparing analgesic properties of breast milk and sucrose in preterm neonates, along with insufficient evidence of sucrose as mentioned earlier, The investigator conducted this prospective randomized controlled trial (RCT) comparing sucrose with breast milk for pain relief in preterm neonates.
The primary objective of the study is to compare pain scores between two groups (24% sucrose and breast milk) during blood draw by automated heel lancet, in preterm neonates. The pain scores between the two groups will also be compared at 30 seconds intervals until two minutes post-procedure.
The current study is conducted at Hutzel Women's Hospital and Children's Hospital of Michigan NICU. Institutional Review Board approval was obtained from Wayne State University prior to study initiation. Before the study was initiated, physicians were trained in assessing the PIPP-R pain scale. The pain scores were given by two physicians who were blinded to the treatment arm, at baseline, during, 30-, 60-, 90-, and 120 seconds post-procedure. These scores were given either at the time of the procedure or a video is recorded to be scored later.
Eligible participants were identified and written informed consent was obtained from the parents. The timing and need for a blood draw are decided by the clinical team and are performed by the nurse taking care of the participant. Randomization was done by the pharmacist through a computer-generated program. Participants were randomly assigned to receive either 0.5 ml 24 % sucrose or 2 ml breastmilk, 2 minutes prior to the procedure. On the day of the procedure, the pharmacist sent a closed sealed envelope with a randomization group to the nurse taking care of the participant. Pain scores are given by two physicians during and post-procedure.
Te Investigators collected maternal characteristics of participants like age, prenatal care, race, history of diabetes and hypertension, receipt of antenatal steroids, magnesium, histological diagnosis of chorioamnionitis, mode of delivery, and duration of rupture of membranes. Neonatal characteristics collected include sex, APGAR score at 1 and 5 minutes, birth weight, gestational age, weight on the day of the procedure, postmenstrual age, number of skin pricks prior to the day of the procedure, and adverse events pre-defined as heart rate >240beats/minute or heart rate <80 beats/minute for >20 seconds, oxygen saturation <80 for >20 seconds, no spontaneous respiration for >20 seconds, choking, gagging were collected.
For this non-inferiority trial, the investigators chose the clinically significant difference to be 2 between the median PIPP-R scores during the procedure The investigators required 88 patients (44 in each group) to show that the lower limit of one-sided 95 % CI will be above the non-inferiority limit of -2 for an alpha error of 5% and power of 90 %.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pain
Keywords
Pain management in preterm neonates
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
88 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Breast Milk
Arm Type
Active Comparator
Arm Description
2 ml of Breast milk given one time, two minutes prior to the heel lance
Arm Title
24 %Sucrose
Arm Type
Other
Arm Description
0.5 ml sucrose to be given once, two minutes prior to the heel lance
Intervention Type
Other
Intervention Name(s)
Breast Human Milk
Intervention Description
Interventional drug is given to the neonates 2 minutes before the heel lance
Intervention Type
Other
Intervention Name(s)
24 % Sucrose
Intervention Description
0.5 ml of sucrose given once 2 minutes prior to procedure
Primary Outcome Measure Information:
Title
Pain Profile
Description
Premature Infant Pain Profile- Revised pain profile is used to give pain scores to the participants. Minimum score and maximum scores on the scale are zero and twenty one. The pain scores increases with increasing severity of pain.
Time Frame
During the Procedure
Secondary Outcome Measure Information:
Title
Pain Profile
Description
Premature Infant Pain Profile- Revised pain profile is used to give pain scores to the participants.
Time Frame
Pain scores will be given at 30 seconds interval for 2 minutes, post-procedure
10. Eligibility
Sex
All
Minimum Age & Unit of Time
1 Day
Maximum Age & Unit of Time
30 Days
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
All Infants with gestational age between 30 1/7 and 36 6/7 weeks
Within 30 days of post-natal life
Breast milk is available for the neonate
Scheduled for a blood draw
Exclusion Criteria:
Neonates on intravenous or peroral medications for sedation/analgesia or anti-epileptics
Infants diagnosed with neonatal abstinence syndrome and neonatal encephalopathy
Infants who are critically ill, on assisted ventilation > 2L HFNC and on ionotropic support
Infants with major congenital abnormalities/dysmorphism
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Pradeep Velumula, MD
Organizational Affiliation
Detroit Medical Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
Detroit Medical center
City
Detroit
State/Province
Michigan
ZIP/Postal Code
48201
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
Undecided
Citations:
PubMed Identifier
28414522
Citation
Sener Taplak A, Erdem E. A Comparison of Breast Milk and Sucrose in Reducing Neonatal Pain During Eye Exam for Retinopathy of Prematurity. Breastfeed Med. 2017 Jun;12:305-310. doi: 10.1089/bfm.2016.0122. Epub 2017 Apr 17.
Results Reference
background
PubMed Identifier
23235618
Citation
Shah PS, Herbozo C, Aliwalas LL, Shah VS. Breastfeeding or breast milk for procedural pain in neonates. Cochrane Database Syst Rev. 2012 Dec 12;12(12):CD004950. doi: 10.1002/14651858.CD004950.pub3.
Results Reference
background
PubMed Identifier
22392168
Citation
Simonse E, Mulder PG, van Beek RH. Analgesic effect of breast milk versus sucrose for analgesia during heel lance in late preterm infants. Pediatrics. 2012 Apr;129(4):657-63. doi: 10.1542/peds.2011-2173. Epub 2012 Mar 5.
Results Reference
background
PubMed Identifier
28984527
Citation
Corrigendum to "Analgesic Effect of Maternal Human Milk Odor on Premature Neonates: A Randomized Controlled Trial". J Hum Lact. 2017 Nov;33(4):822. doi: 10.1177/0890334417733738.
Results Reference
background
PubMed Identifier
23707040
Citation
Badiee Z, Asghari M, Mohammadizadeh M. The calming effect of maternal breast milk odor on premature infants. Pediatr Neonatol. 2013 Oct;54(5):322-5. doi: 10.1016/j.pedneo.2013.04.004. Epub 2013 May 23.
Results Reference
background
PubMed Identifier
9164777
Citation
Blass EM. Milk-induced hypoalgesia in human newborns. Pediatrics. 1997 Jun;99(6):825-9. doi: 10.1542/peds.99.6.825.
Results Reference
background
PubMed Identifier
35197549
Citation
Velumula PK, Elbakoush F, Tabb C 2nd, Farooqi A, Lulic-Botica M, Jani S, Natarajan G, Bajaj M. Breast milk vs 24% sucrose for procedural pain relief in preterm neonates: a non-inferiority randomized controlled trial. J Perinatol. 2022 Jul;42(7):914-919. doi: 10.1038/s41372-022-01352-2. Epub 2022 Feb 23.
Results Reference
derived
Learn more about this trial
Breast Milk vs Sucrose in Relieving Procedural Pain in Preterm Neonates During Blood Draw by Automated Heel Lance
We'll reach out to this number within 24 hrs